Western blotting of six pairs of patients’ tumor-TAE tissues also shows a higher level of MLKL in tumor tissues, whesrea the RIP1 and RIP3 levels vary between different patients (Fig. 1g). This evidence concerns the gene MLKL and neoplasm.